JPWO2021184062A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021184062A5 JPWO2021184062A5 JP2022555836A JP2022555836A JPWO2021184062A5 JP WO2021184062 A5 JPWO2021184062 A5 JP WO2021184062A5 JP 2022555836 A JP2022555836 A JP 2022555836A JP 2022555836 A JP2022555836 A JP 2022555836A JP WO2021184062 A5 JPWO2021184062 A5 JP WO2021184062A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- composition
- peptide
- use according
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 15
- 108090000765 processed proteins & peptides Proteins 0.000 claims 10
- 206010057190 Respiratory tract infections Diseases 0.000 claims 3
- 241000700605 Viruses Species 0.000 claims 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 241000711573 Coronaviridae Species 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 241000712461 unidentified influenza virus Species 0.000 claims 2
- 241000282472 Canis lupus familiaris Species 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 201000003883 Cystic fibrosis Diseases 0.000 claims 1
- 241000709661 Enterovirus Species 0.000 claims 1
- 241000283086 Equidae Species 0.000 claims 1
- 241000282326 Felis catus Species 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 241000351643 Metapneumovirus Species 0.000 claims 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 claims 1
- 241000709664 Picornaviridae Species 0.000 claims 1
- 241000725643 Respiratory syncytial virus Species 0.000 claims 1
- 208000036142 Viral infection Diseases 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 1
- 230000000241 respiratory effect Effects 0.000 claims 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 claims 1
- 241000701161 unidentified adenovirus Species 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020900807 | 2020-03-16 | ||
| AU2020900807A AU2020900807A0 (en) | 2020-03-16 | Compositions for treating respiratory tract infection and uses thereof | |
| AU2020900818 | 2020-03-17 | ||
| AU2020900818A AU2020900818A0 (en) | 2020-03-17 | Compositions for treating respiratory tract infection and uses thereof | |
| AU2020904226 | 2020-11-16 | ||
| AU2020904226A AU2020904226A0 (en) | 2020-11-16 | Compositions for treating respiratory tract infection and uses thereof | |
| PCT/AU2021/050229 WO2021184062A1 (en) | 2020-03-16 | 2021-03-16 | Compositions for treating respiratory tract infection and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023518376A JP2023518376A (ja) | 2023-05-01 |
| JPWO2021184062A5 true JPWO2021184062A5 (https=) | 2024-03-27 |
| JP2023518376A5 JP2023518376A5 (https=) | 2024-03-27 |
Family
ID=77767913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022555836A Withdrawn JP2023518376A (ja) | 2020-03-16 | 2021-03-16 | 気道感染症を治療するための組成物およびそれらの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230256059A1 (https=) |
| EP (1) | EP4121084A4 (https=) |
| JP (1) | JP2023518376A (https=) |
| CN (1) | CN115297882A (https=) |
| AU (1) | AU2021237981A1 (https=) |
| CA (1) | CA3171917A1 (https=) |
| WO (1) | WO2021184062A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021003531A1 (en) * | 2019-07-09 | 2021-01-14 | Lateral IP Pty Ltd | Peptides and uses thereof |
| JP2024516327A (ja) * | 2021-05-07 | 2024-04-12 | ラテラル、ファーマ、プロプライエタリー、リミテッド | 炎症性気道疾患を処置するための組成物及びその使用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI20080333A0 (fi) * | 2008-05-02 | 2008-05-02 | Glykos Finland Oy | Influenssaviruksen nukleiinihappoja ja peptidejä |
| BR112014013757A2 (pt) * | 2011-12-09 | 2019-08-27 | Metabolic Pharmaceuticals Pty Ltd | método para tratar osteoartrite; método para tratar uma condição que envolve condrócitos funcionais insuficientes ou tecido cartilaginoso funcional insuficiente; e uso de um peptídeo |
| US9139626B2 (en) * | 2012-09-13 | 2015-09-22 | The Mitre Corporation | Mitrecin A polypeptide with antimicrobial activity |
| SG11202006669RA (en) * | 2018-01-15 | 2020-08-28 | Lateral IP Pty Ltd | Peptides and uses thereof |
| KR20220124196A (ko) * | 2019-12-27 | 2022-09-13 | 레터럴 아이피 피티와이 리미티드 | 사이클릭 펩티드 수용체 란티오닌 신테타제 c-유사 단백질 (lancl) 및 이의 용도 |
-
2021
- 2021-03-16 WO PCT/AU2021/050229 patent/WO2021184062A1/en not_active Ceased
- 2021-03-16 AU AU2021237981A patent/AU2021237981A1/en not_active Abandoned
- 2021-03-16 CA CA3171917A patent/CA3171917A1/en active Pending
- 2021-03-16 JP JP2022555836A patent/JP2023518376A/ja not_active Withdrawn
- 2021-03-16 CN CN202180021765.1A patent/CN115297882A/zh active Pending
- 2021-03-16 EP EP21770411.3A patent/EP4121084A4/en not_active Withdrawn
- 2021-03-16 US US17/911,972 patent/US20230256059A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004505046A5 (https=) | ||
| CN102325532B (zh) | 用于减轻肺部炎症的左氧氟沙星吸入剂 | |
| JP2004538303A5 (https=) | ||
| CN113304166B (zh) | 核苷类化合物在制备治疗冠状病毒感染性疾病的药物中的用途 | |
| AU2002351181B2 (en) | Methods and compositions for treating lesions of the respiratory epithelium | |
| JP2014518268A5 (https=) | ||
| BR0015908A (pt) | Emprego de compostos org nicos no tratamento de doenças | |
| US20090227511A1 (en) | Methods and compositions for treating lesions of the respiratory epithelium | |
| JP2002532520A (ja) | 気道病治療および気道用薬剤送達のための化合物および方法 | |
| FI3710036T3 (fi) | Stabiileja askorbiinihappokoostumuksia ja menetelmiä niiden käyttämiseksi | |
| JP2020516689A5 (https=) | ||
| JPWO2021184062A5 (https=) | ||
| TW200838556A (en) | Pharmaceutical composition for inhibiting the syndrome of snore and preparation thereof | |
| JP2008502699A5 (https=) | ||
| JPWO2021191592A5 (https=) | ||
| Kemper et al. | Treatment of smoke inhalation in five horses | |
| CN105770862A (zh) | 干扰素的干粉吸入剂 | |
| JP2010523662A5 (https=) | ||
| Mäkelä et al. | Treatment of respiratory syncytial virus infections in children | |
| JPWO2020257248A5 (https=) | ||
| JPWO2021138682A5 (https=) | ||
| BR0014246A (pt) | Utilização de uma proteìna ompa de enterobactéria, ou um de seus fragmentos, associada a um peptìdeo imunogênico derivado do vìrus respiratório sincicial | |
| JPH09227373A (ja) | 抗インフルエンザウイルス剤 | |
| WO2021240375A1 (en) | Methotrexate for use in the pharmaceutical or veterinary prevention and/or treatment of viral infections | |
| JPWO2021222740A5 (https=) |